Are P & G Health Ltd latest results good or bad?
Procter & Gamble Health Ltd's latest results are strong, with a 107.34% increase in Profit Before Tax and a 19.33% rise in net sales, indicating significant growth and solid profitability in the pharmaceuticals and biotechnology sector.
Procter & Gamble Health Ltd has reported notable financial results for the quarter ending June 2025, demonstrating significant growth across various key metrics. The company's Profit Before Tax (PBT) reached Rs 84.78 crore, reflecting a year-on-year growth of 107.34%. The Profit After Tax (PAT) also showed a substantial increase, standing at Rs 66.18 crore, which is a remarkable growth of 109.3% compared to the previous year.Net sales for the quarter hit a record high of Rs 338.74 crore, marking a year-on-year growth of 19.33%, a positive shift from the previous year's decline. Additionally, the Operating Profit, excluding other income, showed a robust increase, with a year-on-year growth of 87.23%. The Operating Profit Margin, excluding other income, was reported at 26.67%, indicating a solid performance in profitability.
While the non-operating income for the quarter was recorded at Rs 4.03 crore, the highest in five quarters, this raises considerations regarding the sustainability of income from non-business activities. Overall, Procter & Gamble Health Ltd's financial results indicate a strong position within the pharmaceuticals and biotechnology industry.
Furthermore, the company saw an adjustment in its evaluation, reflecting its robust performance in the recent quarter.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
